Literature DB >> 25088215

Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma.

Hanène Ayari1,2, Liliana Legedz1, Catherine Cerutti1, Pierre Lantelme1, Patrick Feugier1, Marie-Paule Gustin1, Olivier Lohez1, Ali Nehme1, Jacques Yuan Li1, Jouda Gharbi-Chihi2, Giampiero Bricca3.   

Abstract

UNLABELLED: The involvement of the renin-angiotensin-aldosterone system (RAAS) and cortisol in increased cardiovascular risk is well known. If numerous relationships between RAAS and corticosteroids have been described, their interactions within the arterial wall, especially during the transdifferentiation of vascular smooth muscle cells (VSMCs) and the atheroma formation, are not established. Here, we clarified the relationships between mRNA levels of corticosteroid and angiotensin system components using cortisol, fludrocortisone, and angiotensin II treatments of cultured VSMCs maintained in a contractile phenotype or induced to a lipid storing phenotype. We then determined the quantitative relationships between the mRNA content of these components measured with reverse transcription polymerase chain reaction (RT-PCR), in the atheroma plaque and nearby macroscopically intact tissue (MIT) from 27 human carotid endarterectomy samples. In both VSMC phenotypes, cortisol markedly increased both angiotensinogen (AGT) and AT1-receptor (AT1R) mRNA levels. These effects of cortisol were mediated via glucocorticoid receptor-α (GRα) without any illicit activation of the mineralocorticoid receptor (MR). Angiotensin II increased GRα, 11βHSD1, CYP11B1, as well as CYP11B2 mRNAs and decreased AT1R in contractile VSMC; only GRα and CYP11B2 were increased in lipid storing VSMCs, while MR and AGT mRNAs decreased. In endarterectomy specimens, positive correlations between mRNA levels of AGT and aldosterone synthase or 11βHSD1 in MIT and of AT1R and MR in atheroma were detected. The arterial tissue angiotensin system is a target for local glucocorticoids and arterial glucocorticoids for angiotensin II. Both systems appear activated in lipid storing VSMCs and strongly correlated in vivo, and their mutual amplification may contribute to the development of atheroma. KEY MESSAGE: Cortisol increases angiotensin II signaling in VSMCs via GRα. Angiotensin II stimulates cortisol signaling through increased GRα and 11β-HSD1. Corticoid and angiotensin receptors are strongly correlated in the arterial wall. These correlations are maintained at different stages of atheroma development. An auto-amplification loop between angiotensin and cortisol signaling favors atherogenesis.

Entities:  

Keywords:  Adipocyte; Angiotensin; Artery; Atherosclerosis; Glucocorticoids; Lipid storage; Mineralocorticoids; Nuclear receptors; Transdifferentiation; Type 2 diabetes

Mesh:

Substances:

Year:  2014        PMID: 25088215     DOI: 10.1007/s00109-014-1193-7

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma.

Authors:  Wassim Hodroj; Liliana Legedz; Nabil Foudi; Catherine Cerutti; Marie-Claude Bourdillon; Patrick Feugier; Michel Beylot; Jacques Randon; Giampiero Bricca
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-14       Impact factor: 8.311

2.  Vascular angiotensin-converting enzyme expression regulates local angiotensin II.

Authors:  D N Müller; J Bohlender; K F Hilgers; D Dragun; O Costerousse; J Ménard; F C Luft
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

3.  World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

Authors: 
Journal:  Cardiovasc Res       Date:  1997-07       Impact factor: 10.787

4.  Auto-amplification of cortisol actions in human carotid atheroma is linked to arterial remodeling and stroke.

Authors:  Hanène Ayari; Liliana Legedz; Pierre Lantelme; Patrick Feugier; Jacques Randon; Catherine Cerutti; Olivier Lohez; Jean-Yves Scoazec; Jacques Yuan Li; Jouda Gharbi-Chihi; Giampiero Bricca
Journal:  Fundam Clin Pharmacol       Date:  2012-10-02       Impact factor: 2.748

Review 5.  11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus.

Authors:  G Hollis; R Huber
Journal:  Diabetes Obes Metab       Date:  2011-01       Impact factor: 6.577

6.  Expression of cardiac angiotensin II AT1 receptor genes in rat hearts is regulated by steroids but not by angiotensin II.

Authors:  R Della Bruna; S Ries; C Himmelstoss; A Kurtz
Journal:  J Hypertens       Date:  1995-07       Impact factor: 4.844

7.  Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

Authors:  Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Cathepsin G is associated with atheroma formation in human carotid artery.

Authors:  Liliana Legedz; Jacques Randon; Carmine Sessa; Jean-Philippe Baguet; Patrick Feugier; Catherine Cerutti; John McGregor; Giampiero Bricca
Journal:  J Hypertens       Date:  2004-01       Impact factor: 4.844

9.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

10.  Hormonal and pharmacological alteration of angiotensinogen secretion from rat hepatocytes.

Authors:  M Stuzmann; R Radziwill; K Komischke; C Klett; E Hackenthal
Journal:  Biochim Biophys Acta       Date:  1986-04-08
View more
  5 in total

Review 1.  Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?

Authors:  Ali Nehme; Kazem Zibara
Journal:  Hypertens Res       Date:  2017-07-06       Impact factor: 3.872

2.  Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis.

Authors:  Ali Nehme; Catherine Cerutti; Nedra Dhaouadi; Marie Paule Gustin; Pierre-Yves Courand; Kazem Zibara; Giampiero Bricca
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

Review 3.  Therapeutic Interference With Vascular Calcification-Lessons From Klotho-Hypomorphic Mice and Beyond.

Authors:  Florian Lang; Christina Leibrock; Lisann Pelzl; Meinrad Gawaz; Burkert Pieske; Ioana Alesutan; Jakob Voelkl
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-04       Impact factor: 5.555

Review 4.  Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.

Authors:  Joshua R Cook; John Ausiello
Journal:  Rev Endocr Metab Disord       Date:  2021-07-01       Impact factor: 9.306

5.  Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.

Authors:  Ioana Alesutan; Jakob Voelkl; Martina Feger; Denise V Kratschmar; Tatsiana Castor; Sobuj Mia; Michael Sacherer; Robert Viereck; Oliver Borst; Christina Leibrock; Meinrad Gawaz; Makoto Kuro-O; Stefan Pilz; Andreas Tomaschitz; Alex Odermatt; Burkert Pieske; Carsten A Wagner; Florian Lang
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.